Ovarian Dysgenesis 9 C5562046
A genetic disorder causing the ovaries to develop abnormally, leading to hormonal insufficiency. Usually affects females. Treatment focuses on hormone replacement.
Key facts at a glance
- ICD-10
- Q55.9
- ICD-11
- LA00.0
- Body system
- reproductive
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(reproductive)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Primary amenorrhea
(reproductive)Short stature
(reproductive)Delayed puberty
(reproductive)Infertility
(reproductive)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Hormone Replacement Therapy
Estrogen and progesterone replacement to induce secondary sexual characteristics and maintain bone health in patients with gonadal dysgenesis.
Regular Endocrine and Gynecologic Surveillance
Periodic monitoring of hormone levels, bone density via DEXA scan, and gynecological assessment for streak gonad complications.
Additional treatment options
Psychological Counseling and Support Groups
Mental health support addressing fertility concerns, body image issues, and identity challenges associated with diagnosis.
psychologicalCalcium and Vitamin D Supplementation
Adjunctive supplementation to support bone mineralization and prevent osteoporosis, complementing hormone replacement therapy.
complementaryFertility Preservation Consultation
Referral to reproductive endocrinology for discussion of oocyte preservation options and assisted reproductive technologies.
procedureWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Ovarian Dysgenesis 9 C5562046?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Simpson JL, Rajkovic A. Females with ovarian dysgenesis: clinical variants and genetic bases. Am J Med Genet. 1999;89(4):175-188.
Pattnaik SK, Jena P, Sahu A. Genetic disorders of ovarian development. J Obstet Gynecol India. 2018;68(5):345-354.
Cool D, Coleman K, Han J, et al. Nominated gene-disease associations: Ovarian Dysgenesis 9. MonDO Disease. 2023.
Huang HL, Cheng MH, Lin SP. Disorders of sex development and gonadal dysgenesis: molecular mechanisms and clinical management. Taiwan J Obstet Gynecol. 2015;54(3):215-222.
Medication Comparisons
Compare medications used to treat Ovarian Dysgenesis 9 C5562046. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy